Pear Therapeutics raises $64M, launches prescription app for opioid use disorder
Summary
Pear Therapeutics secured $64 million in new funding and introduced a prescription app for opioid use disorder. The company targets a healthcare use case, so the news fits the software and digital health audience. The launch adds a new prescribed treatment option that can interest healthcare providers and care programs. The funding round also suggests Pear has capital to expand commercialization and product development.
Funding
Amount
$64.0M
Total raised
Date
January 9, 2019
Announcement date
Investors
-
Lead investors
Company
peartherapeutics.com
Funded company
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected